Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators

Shuai Chen, Jane Murphy, Rachel Toth, David G. Campbell, Nick A. Morrice, Carol Mackintosh (Lead / Corresponding author)

    Research output: Contribution to journalArticle

    134 Citations (Scopus)

    Abstract

    AS160 (Akt substrate of 160kDa) and TBC1D1 are related RabGAPs (Rab GTPase-activating proteins) implicated in regulating the trafficking of GLUT4 (glucose transporter 4) storage vesicles to the cell surface. All animal species examined contain TBC1D1, whereas AS160 evolved with the vertebrates. TBC1D1 has two clusters of phosphorylated residues, either side of the second PTB (phosphotyrosine-binding domain). Each cluster contains a 14-3-3-binding site. When AMPK (AMP-activated protein kinase) is activated in HEK (human embryonic kidney)-293 cells, 14-3-3s bind primarily to pSer(237) (where pSer is phosphorylated serine) in TBC1D1, whereas 14-3-3 binding depends primarily on pThr(596). (where pThr is phosphorylated threonine) in cells stimulated with IGF-1 (insulin-like growth factor 1), EGF (epidermal growth factor) and PMA; and both pSer (237) and pThr(596). contribute to 14-3-3 binding in cells stimulated with forskolin. In HEK-293 cells, LY294002 inhibits phosphorylation of Thr(596) of TBC1D1, and promotes phosphorylation of AMPK and Set 211 of TBC1D1. In vitro phosphorylation experiments indicated regulatory interactions among phosphorylated sites, for example phosphorylation of Ser(235) prevents subsequent phosphorylation of Ser(237). In rat L6 myotubes, endogenous TBC1D1 is strongly phosphorylated on Ser(237) and binds to 14-3-3s in response to the AMPK activators AICAR (5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside), phenformin and A-769662, whereas insulin promotes phosphorylation of Thr(596) but not 14-3-3 binding. In contrast, AS 160 is phosphorylated on its 14-3-3-binding sites (Ser(341) and Thr(642)) and binds to 14-3-3s in response to insulin, but not A-769662, in L6 cells. These findings suggest that TBC1D1 and AS 160 may have complementary roles in regulating vesicle trafficking in response to insulin and AMPK-activating stimuli in skeletal muscle.

    Original languageEnglish
    Pages (from-to)449-459
    Number of pages11
    JournalBiochemical Journal
    Volume409
    Issue number2
    DOIs
    Publication statusPublished - 15 Jan 2008

    Cite this

    @article{2ecd1cdfc942452baddef4943b5605b4,
    title = "Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators",
    abstract = "AS160 (Akt substrate of 160kDa) and TBC1D1 are related RabGAPs (Rab GTPase-activating proteins) implicated in regulating the trafficking of GLUT4 (glucose transporter 4) storage vesicles to the cell surface. All animal species examined contain TBC1D1, whereas AS160 evolved with the vertebrates. TBC1D1 has two clusters of phosphorylated residues, either side of the second PTB (phosphotyrosine-binding domain). Each cluster contains a 14-3-3-binding site. When AMPK (AMP-activated protein kinase) is activated in HEK (human embryonic kidney)-293 cells, 14-3-3s bind primarily to pSer(237) (where pSer is phosphorylated serine) in TBC1D1, whereas 14-3-3 binding depends primarily on pThr(596). (where pThr is phosphorylated threonine) in cells stimulated with IGF-1 (insulin-like growth factor 1), EGF (epidermal growth factor) and PMA; and both pSer (237) and pThr(596). contribute to 14-3-3 binding in cells stimulated with forskolin. In HEK-293 cells, LY294002 inhibits phosphorylation of Thr(596) of TBC1D1, and promotes phosphorylation of AMPK and Set 211 of TBC1D1. In vitro phosphorylation experiments indicated regulatory interactions among phosphorylated sites, for example phosphorylation of Ser(235) prevents subsequent phosphorylation of Ser(237). In rat L6 myotubes, endogenous TBC1D1 is strongly phosphorylated on Ser(237) and binds to 14-3-3s in response to the AMPK activators AICAR (5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside), phenformin and A-769662, whereas insulin promotes phosphorylation of Thr(596) but not 14-3-3 binding. In contrast, AS 160 is phosphorylated on its 14-3-3-binding sites (Ser(341) and Thr(642)) and binds to 14-3-3s in response to insulin, but not A-769662, in L6 cells. These findings suggest that TBC1D1 and AS 160 may have complementary roles in regulating vesicle trafficking in response to insulin and AMPK-activating stimuli in skeletal muscle.",
    author = "Shuai Chen and Jane Murphy and Rachel Toth and Campbell, {David G.} and Morrice, {Nick A.} and Carol Mackintosh",
    year = "2008",
    month = "1",
    day = "15",
    doi = "10.1042/BJ20071114",
    language = "English",
    volume = "409",
    pages = "449--459",
    journal = "Biochemical Journal",
    issn = "0264-6021",
    publisher = "Portland Press",
    number = "2",

    }

    Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators. / Chen, Shuai; Murphy, Jane; Toth, Rachel; Campbell, David G.; Morrice, Nick A.; Mackintosh, Carol (Lead / Corresponding author).

    In: Biochemical Journal, Vol. 409, No. 2, 15.01.2008, p. 449-459.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators

    AU - Chen, Shuai

    AU - Murphy, Jane

    AU - Toth, Rachel

    AU - Campbell, David G.

    AU - Morrice, Nick A.

    AU - Mackintosh, Carol

    PY - 2008/1/15

    Y1 - 2008/1/15

    N2 - AS160 (Akt substrate of 160kDa) and TBC1D1 are related RabGAPs (Rab GTPase-activating proteins) implicated in regulating the trafficking of GLUT4 (glucose transporter 4) storage vesicles to the cell surface. All animal species examined contain TBC1D1, whereas AS160 evolved with the vertebrates. TBC1D1 has two clusters of phosphorylated residues, either side of the second PTB (phosphotyrosine-binding domain). Each cluster contains a 14-3-3-binding site. When AMPK (AMP-activated protein kinase) is activated in HEK (human embryonic kidney)-293 cells, 14-3-3s bind primarily to pSer(237) (where pSer is phosphorylated serine) in TBC1D1, whereas 14-3-3 binding depends primarily on pThr(596). (where pThr is phosphorylated threonine) in cells stimulated with IGF-1 (insulin-like growth factor 1), EGF (epidermal growth factor) and PMA; and both pSer (237) and pThr(596). contribute to 14-3-3 binding in cells stimulated with forskolin. In HEK-293 cells, LY294002 inhibits phosphorylation of Thr(596) of TBC1D1, and promotes phosphorylation of AMPK and Set 211 of TBC1D1. In vitro phosphorylation experiments indicated regulatory interactions among phosphorylated sites, for example phosphorylation of Ser(235) prevents subsequent phosphorylation of Ser(237). In rat L6 myotubes, endogenous TBC1D1 is strongly phosphorylated on Ser(237) and binds to 14-3-3s in response to the AMPK activators AICAR (5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside), phenformin and A-769662, whereas insulin promotes phosphorylation of Thr(596) but not 14-3-3 binding. In contrast, AS 160 is phosphorylated on its 14-3-3-binding sites (Ser(341) and Thr(642)) and binds to 14-3-3s in response to insulin, but not A-769662, in L6 cells. These findings suggest that TBC1D1 and AS 160 may have complementary roles in regulating vesicle trafficking in response to insulin and AMPK-activating stimuli in skeletal muscle.

    AB - AS160 (Akt substrate of 160kDa) and TBC1D1 are related RabGAPs (Rab GTPase-activating proteins) implicated in regulating the trafficking of GLUT4 (glucose transporter 4) storage vesicles to the cell surface. All animal species examined contain TBC1D1, whereas AS160 evolved with the vertebrates. TBC1D1 has two clusters of phosphorylated residues, either side of the second PTB (phosphotyrosine-binding domain). Each cluster contains a 14-3-3-binding site. When AMPK (AMP-activated protein kinase) is activated in HEK (human embryonic kidney)-293 cells, 14-3-3s bind primarily to pSer(237) (where pSer is phosphorylated serine) in TBC1D1, whereas 14-3-3 binding depends primarily on pThr(596). (where pThr is phosphorylated threonine) in cells stimulated with IGF-1 (insulin-like growth factor 1), EGF (epidermal growth factor) and PMA; and both pSer (237) and pThr(596). contribute to 14-3-3 binding in cells stimulated with forskolin. In HEK-293 cells, LY294002 inhibits phosphorylation of Thr(596) of TBC1D1, and promotes phosphorylation of AMPK and Set 211 of TBC1D1. In vitro phosphorylation experiments indicated regulatory interactions among phosphorylated sites, for example phosphorylation of Ser(235) prevents subsequent phosphorylation of Ser(237). In rat L6 myotubes, endogenous TBC1D1 is strongly phosphorylated on Ser(237) and binds to 14-3-3s in response to the AMPK activators AICAR (5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside), phenformin and A-769662, whereas insulin promotes phosphorylation of Thr(596) but not 14-3-3 binding. In contrast, AS 160 is phosphorylated on its 14-3-3-binding sites (Ser(341) and Thr(642)) and binds to 14-3-3s in response to insulin, but not A-769662, in L6 cells. These findings suggest that TBC1D1 and AS 160 may have complementary roles in regulating vesicle trafficking in response to insulin and AMPK-activating stimuli in skeletal muscle.

    UR - http://www.scopus.com/inward/record.url?scp=38749110036&partnerID=8YFLogxK

    U2 - 10.1042/BJ20071114

    DO - 10.1042/BJ20071114

    M3 - Article

    VL - 409

    SP - 449

    EP - 459

    JO - Biochemical Journal

    JF - Biochemical Journal

    SN - 0264-6021

    IS - 2

    ER -